Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study
- PMID: 21087069
- DOI: 10.2165/11584790-000000000-00000
Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study
Abstract
Background: Osteoporosis is a significant health problem, especially for older women. Prescription osteoporosis medication can reduce fractures, but many women do not accept treatment or discontinue treatment before benefits are achieved.
Objectives: To explore older women's views about prescription osteoporosis medication use in depth and to identify specific beliefs and experiences that influence these views.
Methods: We conducted in-depth telephone interviews with women aged ≥65 years with clinically confirmed osteoporosis. Interviewees were asked about their beliefs and experiences related to osteoporosis and osteoporosis treatment. Interviews were recorded and transcribed; key themes were identified using qualitative analysis.
Results: Perceived need, medication effectiveness and medication safety were identified as critical influences on women's views about prescription osteoporosis medication. These perceptions were in turn influenced by various beliefs, experiences and behaviours, including interactions with the physician, personal experience and behaviours, and vicarious experience.
Conclusions: Older women with osteoporosis need clear information about their condition, including the diagnosis, the implications of the diagnosis, treatment options, medication effectiveness and side effects. Physicians should check with their patients to confirm understanding and address concerns, as older women may not always voice their reservations and concerns.
Similar articles
-
Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: a phenomenological hermeneutic study.Int J Qual Stud Health Well-being. 2014 Feb 21;9:22438. doi: 10.3402/qhw.v9.22438. eCollection 2014. Int J Qual Stud Health Well-being. 2014. PMID: 24559545 Free PMC article.
-
The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.Curr Med Res Opin. 2007 Dec;23(12):3137-52. doi: 10.1185/030079907X242890. Curr Med Res Opin. 2007. PMID: 17988435
-
Effect of the women's health initiative on prescription anti-osteoporosis medication utilization.Osteoporos Int. 2008 Nov;19(11):1603-12. doi: 10.1007/s00198-008-0607-1. Epub 2008 Mar 29. Osteoporos Int. 2008. PMID: 18373048
-
Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.Postgrad Med. 2011 Mar;123(2):131-44. doi: 10.3810/pgm.2011.03.2271. Postgrad Med. 2011. PMID: 21474901 Review.
-
Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies.PLoS One. 2020 Jan 15;15(1):e0227765. doi: 10.1371/journal.pone.0227765. eCollection 2020. PLoS One. 2020. PMID: 31940409 Free PMC article.
Cited by
-
Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use.Res Social Adm Pharm. 2021 Jul;17(7):1267-1275. doi: 10.1016/j.sapharm.2020.09.010. Epub 2020 Sep 20. Res Social Adm Pharm. 2021. PMID: 33011082 Free PMC article.
-
Women's lived experiences of learning to live with osteoporosis: a longitudinal qualitative study.BMC Womens Health. 2017 Mar 9;17(1):17. doi: 10.1186/s12905-017-0377-z. BMC Womens Health. 2017. PMID: 28279157 Free PMC article.
-
Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.Int J Clin Pharm. 2015 Oct;37(5):949-57. doi: 10.1007/s11096-015-0147-7. Epub 2015 Jun 6. Int J Clin Pharm. 2015. PMID: 26047944
-
A qualitative systematic review of patients' experience of osteoporosis using meta-ethnography.Arch Osteoporos. 2016 Dec;11(1):33. doi: 10.1007/s11657-016-0286-z. Epub 2016 Oct 13. Arch Osteoporos. 2016. PMID: 27739032 Free PMC article.
-
Current situation of shared decision making in osteoporosis: A comprehensive literature review of patient decision aids and decision drivers.Health Sci Rep. 2022 Nov 21;5(6):e849. doi: 10.1002/hsr2.849. eCollection 2022 Nov. Health Sci Rep. 2022. PMID: 36425899 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources